Guangzhou Improve Med Instrument Strategic Asset Allocation Index
Guangzhou Improve Med Instrument strategic asset allocation index. Guangzhou Improve Med Instrument (300030) has a Strategic Asset Allocation Index of 47.0% as of June 2023. Strategic assets (PP&E of CN¥391.14 Million plus long-term investments of CN¥-) total CN¥391.14 Million, measured against net assets of CN¥832.17 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Guangzhou Improve Med Instrument (300030) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guangzhou Improve Med Instrument (2006–2022)
Strategic asset allocation index of Guangzhou Improve Med Instrument from 2006 to 2022. This chart shows how Guangzhou Improve Med Instrument's Strategic Asset Allocation Index has evolved across 17 annual periods from 2006 to 2022. As of June 2023, the index stands at 47.0%, representing strategic assets of CN¥391.14 Million against net assets of CN¥832.17 Million CNY. Check tangible equity quality of Guangzhou Improve Med Instrument to evaluate the tangible quality of the company's equity base.
Guangzhou Improve Med Instrument Strategic Asset Allocation Index by Year (2006–2022)
Guangzhou Improve Med Instrument strategic asset allocation index by year from 2006 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Improve Med Instrument from 2006 to 2022, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Guangzhou Improve Med Instrument stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 49.6% | CN¥407.12 Million | CN¥407.12 Million | CN¥- | CN¥820.61 Million | ▲ +10.0 pp |
| 2021 | 39.6% | CN¥408.54 Million | CN¥408.54 Million | CN¥- | CN¥1.03 Billion | ▲ +5.0 pp |
| 2020 | 34.6% | CN¥347.45 Million | CN¥347.45 Million | CN¥- | CN¥1.00 Billion | ▼ -25.2 pp |
| 2019 | 59.9% | CN¥501.93 Million | CN¥305.29 Million | CN¥196.64 Million | CN¥838.26 Million | ▲ +0.3 pp |
| 2018 | 59.6% | CN¥485.70 Million | CN¥308.90 Million | CN¥176.80 Million | CN¥815.47 Million | ▲ +7.9 pp |
| 2017 | 51.7% | CN¥498.11 Million | CN¥321.51 Million | CN¥176.60 Million | CN¥963.72 Million | ▲ +0.7 pp |
| 2016 | 51.0% | CN¥486.58 Million | CN¥312.97 Million | CN¥173.60 Million | CN¥954.18 Million | ▲ +0.0 pp |
| 2015 | 50.9% | CN¥474.04 Million | CN¥316.12 Million | CN¥157.92 Million | CN¥930.46 Million | ▲ +15.0 pp |
| 2014 | 36.0% | CN¥281.32 Million | CN¥281.32 Million | CN¥- | CN¥782.00 Million | ▲ +6.2 pp |
| 2013 | 29.8% | CN¥230.37 Million | CN¥230.37 Million | CN¥- | CN¥772.70 Million | ▼ -2.1 pp |
| 2012 | 31.9% | CN¥219.68 Million | CN¥219.68 Million | CN¥- | CN¥687.93 Million | ▲ +0.5 pp |
| 2011 | 31.4% | CN¥203.84 Million | CN¥203.84 Million | CN¥- | CN¥648.25 Million | ▲ +6.4 pp |
| 2010 | 25.1% | CN¥148.61 Million | CN¥148.61 Million | CN¥- | CN¥592.55 Million | ▲ +7.9 pp |
| 2009 | 17.2% | CN¥97.00 Million | CN¥97.00 Million | CN¥- | CN¥563.53 Million | ▼ -44.4 pp |
| 2008 | 61.6% | CN¥48.49 Million | CN¥48.49 Million | CN¥- | CN¥78.73 Million | ▲ +46.4 pp |
| 2007 | 15.1% | CN¥8.83 Million | CN¥8.83 Million | CN¥- | CN¥58.27 Million | ▼ -13.9 pp |
| 2006 | 29.1% | CN¥5.62 Million | CN¥5.62 Million | CN¥- | CN¥19.33 Million | — |